Literature DB >> 24112734

Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.

Pitak Chanthammachat1, Waraporn Promwikorn, Kowit Pruegsanusak, Sittiruk Roytrakul, Chantragan Srisomsap, Daranee Chokchaichamnankit, Jisnuson Svasti, Pleumjit Boonyaphiphat, Singkhamanan K, Paramee Thongsuksai.   

Abstract

OBJECTIVE: The study was aimed at analysing and identifying the proteins that are differentially expressed in oral squamous cell carcinoma (OSCC) compared to adjacent non-tumour tissue.
MATERIALS AND METHODS: Two-dimensional (2D) sodium dodecyl sulphate-polyacrylamide gel electrophoresis accompanied by mass spectrometry (matrix-assisted laser desorption/ionisation-time-of-flight mass spectrometry and liquid chromatography-tandem mass spectrometry) was used to analyse and identify the differentially expressed proteins in 10 pairs of tumours and adjacent non-tumour tissues from five cases of early-stage and five cases of late-stage OSCC. The statistical differences of the protein spots were analysed by the Wilcoxon signed-rank test. A validation study using immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) was performed.
RESULTS: A total of 68 proteins (63 up-regulated, five down-regulated) were differentially expressed in early-stage disease, and 39 proteins (37 up-regulated, two down-regulated) were significantly altered in late-stage disease. Among these, 14 proteins were altered in both groups. A total of 44 proteins were identified, including heat shock proteins (HSPs: Hsp90, HSPA5 and HSPA8), keratins (K1, K6A and K17), tubulin, cofilin 1, 14-3-3σ and metabolic enzymes. These proteins are involved in various cellular processes essential for cell growth, survival and cell migration. The validation study on α-tubulin and 14-3-3σ using immunohistochemistry and KIAA1199 expression using real-time RT-PCR confirmed the results in proteomics analysis.
CONCLUSIONS: The study identified many proteins, both known and unknown, for cancer cell processes. At least two proteins, KIAA1199 and Horf6, are novel for oral cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Mass spectrometry; Oral squamous cell carcinoma; Proteomics; Quantitative real-time RT-PCR; Two-dimensional gel electrophoresis

Mesh:

Substances:

Year:  2013        PMID: 24112734     DOI: 10.1016/j.archoralbio.2013.08.002

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  15 in total

1.  Antitumorigenic Effect of Hsp90 Inhibitor SNX-2112 on Tongue Squamous Cell Carcinoma is Enhanced by Low-Intensity Ultrasound.

Authors:  Chuanchuan Nan; Yuyan Zheng; Haidong Fan; Haipeng Sun; Shengxing Huang; Nan Li
Journal:  Onco Targets Ther       Date:  2020-08-12       Impact factor: 4.147

2.  Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer.

Authors:  S S Chauhan; J Kaur; M Kumar; A Matta; G Srivastava; A Alyass; J Assi; I Leong; C MacMillan; I Witterick; T J Colgan; N K Shukla; A Thakar; M C Sharma; K W M Siu; P G Walfish; R Ralhan
Journal:  Oncogenesis       Date:  2015-04-20       Impact factor: 7.485

3.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Authors:  Maria Frantzi; Akshay Bhat; Agnieszka Latosinska
Journal:  Clin Transl Med       Date:  2014-03-29

Review 4.  Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target.

Authors:  Li Li; Lin-Hai Yan; Shwetha Manoj; Ying Li; Lu Lu
Journal:  J Cancer       Date:  2017-07-20       Impact factor: 4.207

5.  Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.

Authors:  Li-Hsing Chi; Wei-Min Chang; Yu-Chan Chang; Yung-Chieh Chan; Chia-Chen Tai; Kam-Wing Leung; Chi-Long Chen; Alexander Th Wu; Tsung-Ching Lai; Yu-Chuan Jack Li; Michael Hsiao
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

6.  KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.

Authors:  Shuqin Jia; Tingting Qu; Xiaohong Wang; Mengmeng Feng; Yang Yang; Xuemin Feng; Ruiting Ma; Wenmei Li; Ying Hu; Yi Feng; Ke Ji; Ziyu Li; Wenguo Jiang; Jiafu Ji
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

7.  KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma.

Authors:  Zhengchen Jiang; Xiangyu Zhai; Binyao Shi; Dan Luo; Bin Jin
Journal:  Onco Targets Ther       Date:  2018-11-23       Impact factor: 4.147

8.  High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.

Authors:  Min Cai; Rukeng Tan; Yunyi Huang; Xuanyi Chen; Qingci Kong; Kaixin Guo; Meng Xu
Journal:  Pathol Oncol Res       Date:  2021-04-16       Impact factor: 3.201

9.  Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach.

Authors:  Yan Dong; Qun Zhao; Xiaoyan Ma; Guowu Ma; Caiyun Liu; Zhuwen Chen; Liyuan Yu; Xuefeng Liu; Yanguang Zhang; Shujuan Shao; Jing Xiao; Jia Li; Weimin Zhang; Ming Fu; Lijia Dong; Xiandong Yang; Xu Guo; Liyan Xue; Fei Fang; Qimin Zhan; Lihua Zhang
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

10.  Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma.

Authors:  Meixiang Huang; Feifei Liao; Yexun Song; Gang Zuo; Guolin Tan; Ling Chu; Tiansheng Wang
Journal:  PeerJ       Date:  2020-09-07       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.